France Biotechnology & Medical Research

Genoway SA (ALGEN)

Track

Track

Genoway SA recorded five insider trading transactions over the past ninety days. These activities involved total purchases of 149,981.60 EUR alongside sales amounting to 47,448.00 EUR. CEO Alexandre Fraichard significantly increased his holdings through recent acquisitions, while various board members divested portions of their equity stakes following the company's latest results financiers.
Ticker: ALGEN Exchange: PAR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Genoway SA. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.6
Alexandre Fraichard DG Officer
Transaction date
Purchase
Price
223.65
Quantity 26,459
Value €4,464,782
3.6
Alexandre Fraichard DG Officer
Transaction date
Purchase
Price
376.68
Quantity 9,385
Value €1,915,983
ISTYA FOND DE DOTATION ADMINISTRATEUR Director
Transaction date
Sale
Price
299.68
Quantity 89,534
Value €2,629,592
SOLYS SARL ADMINISTRATEUR Director
Transaction date
Sale
Price
2.40
Quantity 4,900
Value €11,760
CARLYS SOCIETE CIVILE ADMINISTRATEUR Director
Transaction date
Sale
Price
2.40
Quantity 10,000
Value €24,000
SOLYS SARL ADMINISTRATEUR Director
Transaction date
Purchase
Price
2.40
Quantity 5,000
Value €12,000
JEAN LOUIS MENARD ADMINISTRATEUR Director
Transaction date
Sale
Price
2.40
Quantity 4,044
Value €9,706
JEAN LOUIS MENARD ADMINISTRATEUR Director
Transaction date
Purchase
Price
2.35
Quantity 38,500
Value €90,475
2.7
olivier Charmeil Administrateur Indépendant Non-Executive Director
Transaction date
Purchase
Price
2.35
Quantity 42,553
Value €100,000
3.6
Florent Pons Directeur Marketing Officer
Transaction date
Purchase
Price
2.80
Quantity 484
Value €1,355
3.6
Florent Pons Directeur Marketing Officer
Transaction date
Purchase
Price
2.80
Quantity 516
Value €1,445
3.6
Alexandre Fraichard Directeur General Officer
Transaction date
Purchase
Price
3.07
Quantity 11,299
Value €34,687
3.6
Alexandre Fraichard Directeur Général Officer
Transaction date
Purchase
Price
3.04
Quantity 12,500
Value €38,054
3.6
Florent Pons Directeur des Opérations Commerciales Officer
Transaction date
Sale
Price
3.90
Quantity 3,880
Value €15,132
3.6
Florent Pons Directeur des Opérations Commerciales Officer
Transaction date
Sale
Price
4.80
Quantity 1,700
Value €8,160
3.8
Christian Grenier Président du CA Director
Transaction date
Sale
Price
4.40
Quantity 5,000
Value €22,000
3.6
Florent Pons Directeur des Opérations Commerciales Officer
Transaction date
Sale
Price
4.20
Quantity 500
Value €2,100
3.6
Florent Pons Directeur des Opérations Commerciales Officer
Transaction date
Sale
Price
3.93
Quantity 700
Value €2,750
3.6
Florent Pons Directeur des Opérations Commerciales Officer
Transaction date
Sale
Price
3.93
Quantity 400
Value €1,570
3.8
Christian Grenier Pdt Conseil d'administration Director
Transaction date
Purchase
Price
4.00
Quantity 5,000
Value €20,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-29 2026-07-27 B Purchase
3.6
Alexandre Fraichard

DG

Officer
26,459
223.65
€4,464,782 		26,459 223.65 €4,464,782
2026-07-20 2026-07-16 B Purchase
3.6
Alexandre Fraichard

DG

Officer
9,385
376.68
€1,915,983 		9,385 376.68 €1,915,983
2026-06-22 2026-06-17 S Sale ISTYA FOND DE DOTATION

ADMINISTRATEUR

Director
89,534
299.68
€2,629,592 		89,534 299.68 €2,629,592
2026-06-22 2026-06-17 S Sale SOLYS SARL

ADMINISTRATEUR

Director
4,900
2.40
€11,760 		4,900 2.40 €11,760
2026-06-22 2026-06-17 S Sale CARLYS SOCIETE CIVILE

ADMINISTRATEUR

Director
10,000
2.40
€24,000 		10,000 2.40 €24,000
2026-06-22 2026-05-28 B Purchase SOLYS SARL

ADMINISTRATEUR

Director
5,000
2.40
€12,000 		5,000 2.40 €12,000
2026-05-29 2026-05-28 S Sale
JEAN LOUIS MENARD

ADMINISTRATEUR

Director
4,044
2.40
€9,706 		4,044 2.40 €9,706
2025-12-23 2025-12-17 B Purchase
JEAN LOUIS MENARD

ADMINISTRATEUR

Director
38,500
2.35
€90,475 		38,500 2.35 €90,475
2025-12-19 2025-12-17 B Purchase
2.7
olivier Charmeil

Administrateur Indépendant

Non-Executive Director
42,553
2.35
€100,000 		42,553 2.35 €100,000
2025-04-15 2025-04-11 B Purchase
3.6
Florent Pons

Directeur Marketing

Officer
484
2.80
€1,355 		484 2.80 €1,355
2025-04-15 2025-04-11 B Purchase
3.6
Florent Pons

Directeur Marketing

Officer
516
2.80
€1,445 		516 2.80 €1,445
2025-04-02 2025-03-31 B Purchase
3.6
Alexandre Fraichard

Directeur General

Officer
11,299
3.07
€34,687 		11,299 3.07 €34,687
2025-01-31 2025-01-31 B Purchase
3.6
Alexandre Fraichard

Directeur Général

Officer
12,500
3.04
€38,054 		12,500 3.04 €38,054
2024-09-30 2024-09-25 S Sale
3.6
Florent Pons

Directeur des Opérations Commerciales

Officer
3,880
3.90
€15,132 		3,880 3.90 €15,132
2024-01-18 2024-01-17 S Sale
3.6
Florent Pons

Directeur des Opérations Commerciales

Officer
1,700
4.80
€8,160 		1,700 4.80 €8,160
2023-12-18 2023-12-15 S Sale
3.8
Christian Grenier

Président du CA

Director
5,000
4.40
€22,000 		5,000 4.40 €22,000
2023-11-27 2023-11-23 S Sale
3.6
Florent Pons

Directeur des Opérations Commerciales

Officer
500
4.20
€2,100 		500 4.20 €2,100
2023-10-26 2023-10-23 S Sale
3.6
Florent Pons

Directeur des Opérations Commerciales

Officer
700
3.93
€2,750 		700 3.93 €2,750
2023-10-26 2023-10-23 S Sale
3.6
Florent Pons

Directeur des Opérations Commerciales

Officer
400
3.93
€1,570 		400 3.93 €1,570
2023-09-26 2023-09-25 B Purchase
3.8
Christian Grenier

Pdt Conseil d'administration

Director
5,000
4.00
€20,000 		5,000 4.00 €20,000
Explore more

More insider trading research around Genoway SA

More insider trades in France
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe